Status:
COMPLETED
A Trial to Evaluate the Efficacy and Safety of EFLA400 Korea Red Ginseng Extract on Sexual Function in Men With Erectile Dysfunction
Lead Sponsor:
Chonbuk National University Hospital
Conditions:
Healthy Subjects(Only Men)
Eligibility:
MALE
19-70 years
Phase:
NA
Brief Summary
Korea red ginseng has been used in maintaining vitality throughout the globally and metabolism and actions on neurologic, cardiovascular, and endocrinologic system are studied. KRG has been used in va...
Detailed Description
Among the three main lines of therapy for erectile dysfunction (ED), that is, oral therapy, self-injection therapy and penile prosthesis implantation, the first line therapy is always the first option...
Eligibility Criteria
Inclusion
- aged 17-70 years
- IIEF(International Index of Erectile Function)-5 scores ≤ 21 subjects.
Exclusion
- they had other neurologic or psychiatric disorder
- significant hepatic or renal function impairment (hepatic enzymes \>1.5 times the upper limit of normal and/or serum creatinine \>1.8 mg per 100 ml)
- hypertension (\>170/110 mm Hg), hypotension (\<90/50 mm Hg) or significant cardiovascular disease (unstable angina, coronary artery disease, myocardial infarction or myocardial revascularization).
- Peyronie's disease
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01479426
Start Date
December 1 2010
End Date
February 1 2012
Last Update
September 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trial Center for Functional Foods; Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea, 560-822